Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease

Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease

While clinically significant cognitive impairment is the key feature of the symptomatic stages of the Alzheimer’s disease (AD) continuum, subtle cognitive decline is now known to occur years before a clinical diagnosis of mild cognitive impairment (MCI) or dementia due to AD is made. The primary aim...

Full description

Bibliographic Details
Main Authors: Rebecca Langhough Koscik, Bruce P. Hermann, Samantha Allison, Lindsay R. Clark, Erin M. Jonaitis, Kimberly D. Mueller, Tobey J. Betthauser, Bradley T. Christian, Lianlian Du, Ozioma Okonkwo, Alex Birdsill, Nathaniel Chin, Carey Gleason, Sterling C. Johnson
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Aging Neuroscience
Subjects:
cognitively unimpaired
subclinical decline
transitional cognitive decline
mild cognitive impairment
Alzheimer’s disease
validity
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.688478/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2021.688478/full

Similar Items